First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …

Further studies are needed to validate CAPA case definitions, to determine the accurate
incidence of CAPA in comparison to adequate controls, and its evolution during the …

Abstract Coronavirus Disease 2019 (COVID-19)-associated pulmonary aspergillosis is an
emerging entity. We report two fatal cases of putative COVID-19-associated pulmonary …

Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …

In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical
manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis …

Our study aims to assess the prevalence of CAPA (COVID-19-associated pulmonary
aspergillosis) and describe the associated risk factors and their impact on mortality. A …

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

An international panel of experts has recently proposed criteria for defining a new clinical
entity called CAPAdcoronavirus disease 2019 (COVID-19)-associated pulmonary …

Background COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an
invasive fungal disease, often affecting previously immunocompetent, mechanically …